NCT00232258 Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study Status COMPLETED Phase PHASE2
NCT00222378 Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT00219414 Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) Status COMPLETED Phase PHASE4
NCT00215020 Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT00209300 Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission Status COMPLETED Phase PHASE3
NCT00209287 Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis Status TERMINATED Phase PHASE4
NCT00207688 A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients Status COMPLETED Phase N/A
NCT00167882 The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels Status COMPLETED Phase PHASE4
NCT00152841 Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT00151892 Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00145015 FishGastro Study: Fish Consumption and Gastro-Intestinal Health Status COMPLETED Phase NA
NCT00114803 Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT00102193 Study for the Treatment of Ulcerative Colitis With Adacolumn Status COMPLETED Phase PHASE3
NCT00096655 A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00092508 CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission Status COMPLETED Phase PHASE3
NCT00073047 Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT00073021 Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis Status COMPLETED Phase PHASE3